Cerus (CERS) vs SS Innovations International (SSII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cerus (CERS) has outperformed SS Innovations International (SSII) over the past year, gaining 43.1% versus a loss of 59.6%. SS Innovations International is the larger company by market cap ($548.0 million vs $461.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | SSII |
|---|---|---|
| Share price | $2.29 | $2.74 |
| Market cap | $461.49M | $548.00M |
| 1-day change | -2.14% | -0.72% |
| YTD return | +11.17% | -51.76% |
| 1-year return | +43.13% | -59.59% |
| 5-year return | -62.58% | — |
| EPS (TTM) | $-0.03 | $-0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $10.00 |
| 52-week low | $1.38 | $2.62 |
| Distance from 52-week high | -34.01% | -72.60% |
| Analyst consensus | none | none |
| Avg. price target upside | +124.02% | +155.47% |
| Average volume | 2.15M | 64.37K |
| Shares outstanding | 201.52M | 200.00M |
| Employees | 261 | 483 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CERS has outperformed SSII by 102.7 percentage points over the past year.
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Healthcare · Medical Devices · 261 employees
About SS Innovations International
SSII stock →SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Healthcare · Medical Devices · 483 employees
CERS vs SSII FAQ
Which is bigger, Cerus or SS Innovations International?
SS Innovations International (SSII) is larger, with a market capitalization of $548.00M compared with $461.49M for Cerus (CERS).
Which stock has performed better over the past year, CERS or SSII?
CERS returned +43.13% over the past 12 months, compared with -59.59% for SSII (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and SS Innovations International in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.